B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cefsulodin

300 PubMed studies analyzed · 3 RCTs · Evidence Score: 45.8

Research Domains

Cefsulodin has been studied across 7 research domains including 🧠 Focus & Attention, 🫘 Kidney, 😴 Sleep, 🫁 Respiratory, 🦠 Gut & Microbiome. The primary research focus is 🧠 Focus & Attention with 7% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cefsulodin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.